FISHKILL, N.Y., Aug. 25, 2011 /PRNewswire/ -- Nano Mask, Inc. (NMI) (Pink Sheets: NANM), a healthcare product development and distribution company focused on emergency and critical care as well as infection control markets, has announced that it has entered into a distribution agreement with a Saudi Arabia-based medical products distributor which will represent NMI's product line on an exclusive basis to: The Kingdom of Saudi Arabia, United Arab Emirates, Kuwait, Egypt, Morocco, Oman, Algeria, Qatar, Jordan, Bahrain, Sudan, Yemen Lebanon, Yemen and Tunisia.
In exchange for four years of exclusive rights to distribute NMI's product line in the Territory, the Saudi Arabian medical products distributor, having already delivered to date over $90,000.00 in orders, has agreed to order a minimum of $ 2,300,000 over the next four years. The products that will be marketed and sold in the Territory are NMI's emergency life support and respiratory products (utilizing the company's industry leading patented 2H Filtration Technology), antimicrobial hospital barrier products and NMI's proprietary line of bacteria free enzymatic medical detergents specially formulated for instrument reprocessing.
"This agreement, which covers 15 Middle Eastern countries, represents the first of what we hope will be many international distribution agreements for our products," said Eddie Suydam, President and CEO, NMI.
Mr. Suydam added, "We are currently in negotiations with other medical products distributors, both domestic and international, to sell our products and expect that we will begin to see some meaningful sales from our marketing efforts in the near future."
About Nano Mask, Inc.
NMI is the inventor of 2H Technology, an advanced dual filtration system which is designed to remove infectious bacteria and virus from airflow systems at extremely high levels of efficiency. In addition to the company's advanced filtration materials and products, NMI also markets a line of innovative infection control products which range from proprietary enzymatic instrument reprocessing solutions to innovative antimicrobial textiles in the United States and internationally.
This release may contain statements that are forward-looking. Such statements are made based upon current expectations that are subject to risk and uncertainty. Specifically, any unforeseen delays in manufacturing and distribution may affect the planned timeline for initiating actual sales of the product. NMI does not undertake to update forward-looking statements in this news release to reflect actual results of and changes in assumptions or changes in other factors affecting such forward-looking information. The actual future plans and results of the company could differ significantly from such forward-looking statements.
For further information:
|SOURCE Nano Mask, Inc.|
Copyright©2010 PR Newswire.
All rights reserved